U.S. Physical Therapy (USPH) Scheduled to Post Quarterly Earnings on Tuesday

U.S. Physical Therapy (NYSE:USPH) is set to post its quarterly earnings results after the market closes on Tuesday, May 7th. Analysts expect U.S. Physical Therapy to post earnings of $0.58 per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.02. U.S. Physical Therapy had a net margin of 4.67% and a return on equity of 8.52%. The business had revenue of $154.80 million for the quarter, compared to the consensus estimate of $150.24 million. During the same quarter in the previous year, the firm earned $0.58 earnings per share. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Price Performance

Shares of USPH stock traded down $0.56 during trading hours on Tuesday, hitting $101.42. The stock had a trading volume of 5,648 shares, compared to its average volume of 68,717. The stock has a market capitalization of $1.53 billion, a price-to-earnings ratio of 75.54, a PEG ratio of 4.77 and a beta of 1.39. U.S. Physical Therapy has a one year low of $78.08 and a one year high of $124.11. The stock’s 50-day moving average price is $105.03 and its two-hundred day moving average price is $95.64. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.28 and a quick ratio of 2.28.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 5th. Stockholders of record on Tuesday, March 12th were paid a dividend of $0.44 per share. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.43. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.74%. The ex-dividend date of this dividend was Monday, March 11th. U.S. Physical Therapy’s payout ratio is currently 130.37%.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Barrington Research upped their price objective on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the company an “outperform” rating in a report on Friday, March 1st. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Monday, March 18th. Finally, JPMorgan Chase & Co. increased their price objective on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and a consensus price target of $125.67.

Insiders Place Their Bets

In other news, CFO Carey P. Hendrickson sold 1,800 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the completion of the sale, the chief financial officer now directly owns 21,186 shares of the company’s stock, valued at $2,272,834.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CFO Carey P. Hendrickson sold 1,800 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total transaction of $193,104.00. Following the sale, the chief financial officer now owns 21,186 shares of the company’s stock, valued at approximately $2,272,834.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Edward L. Kuntz sold 2,500 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $104.26, for a total value of $260,650.00. Following the completion of the sale, the director now owns 5,780 shares in the company, valued at $602,622.80. The disclosure for this sale can be found here. In the last 90 days, insiders sold 10,829 shares of company stock worth $1,141,535. Insiders own 1.80% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.